Actionable news
All posts from Actionable news
Actionable news in SRPT: Sarepta Therapeutics, Inc.,

FDA accepts Marathon Pharma's NDAs for Duchenne candidate deflazacort under accelerated review

The FDA accepts privately held Marathon Pharmaceuticals, LLC's New Drug Applications (NDAs) seeking approval of deflazacort for the treatment of Duchenne muscular dystrophy (DMD). The agency will...